Endo International | Ventes



Sales Changement Date
AbbVie USD 13.34B 1.76B 2025-03
Amarin USD 42.02M 20.29M 2025-03
ANI Pharmaceuticals USD 197.1M 6.5M 2025-03
Bristol-Myers Squibb USD 11.2B 1.14B 2025-03
Eli Lilly USD 12.73B 802.8M 2025-03
Hikma Pharmaceutical USD 1.59B 18M 2024-12
Ligand Pharmaceuticals USD 45.33M 2.52M 2025-03
Merck USD 15.53B 94M 2025-03
Novartis USD 13.15B 330M 2024-12
Pacira USD 168.92M 18.33M 2025-03
Perrigo USD 1.04B 98.3M 2025-03
Pfizer USD 13.72B 4.04B 2025-03
Supernus Pharmaceuticals USD 149.8M 24.36M 2025-03
Takeda JPY 1.05T 90B 2025-03
Teva Pharmaceutical Industries USD 14.06B 1.27B 2025-03
Xeris Pharmaceuticals USD 60.1M 5.83M 2024-12
Zoetis USD 2.22B 97M 2025-03



Endo International Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.